{"version":"https://jsonfeed.org/version/1","title":"InsightReg Consultancy","home_page_url":"https://insightregconsultancy.com","description":"InsightReg Consultancy","author":{"name":"InsightReg Consultancy"},"items":[{"id":"https://insightregconsultancy.com/insights-and-resources/f/aligning-global-regulatory-strategy-across-emea","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/c84931a5-8b09-410e-a6bf-f99270e37461/Designer-58925d6.png\"/><p>Emerging Perspectives in the Middle East and GCC</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/aligning-global-regulatory-strategy-across-emea","title":"Aligning Global Regulatory Strategy Across EMEA","summary":"Emerging Perspectives in the Middle East and GCC","date_modified":"2026-06-13T14:28:46Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/regulatory-science-vs-regulatory-affairs","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/c84931a5-8b09-410e-a6bf-f99270e37461/Designer%20(2).png\"/><p>Understanding the Balance</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/regulatory-science-vs-regulatory-affairs","title":"Regulatory Science vs Regulatory Affairs","summary":"Understanding the Balance","date_modified":"2026-05-20T21:17:59Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/defining-the-boundaries-of-gene-therapy","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/c84931a5-8b09-410e-a6bf-f99270e37461/Designer.png\"/><p>Regulatory Considerations in the MHRA GTMP Consultation</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/defining-the-boundaries-of-gene-therapy","title":"Defining the Boundaries of Gene Therapy","summary":"Regulatory Considerations in the MHRA GTMP Consultation","date_modified":"2026-05-17T11:19:46Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/4-the-future-of-regulatory-affairs","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/2957\"/><p>1. Introduction</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/4-the-future-of-regulatory-affairs","title":"The Future of Regulatory Affairs","summary":"1. Introduction","date_modified":"2026-05-08T20:58:57Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/3-introduction-to-the-common-technical-document-ctd","html_content":"<img src=\"https://img1.wsimg.com/isteam/ip/c84931a5-8b09-410e-a6bf-f99270e37461/ctd_triangle_0-0c112dd.png\"/><p>1. Introduction</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/3-introduction-to-the-common-technical-document-ctd","title":"Introduction to the Common Technical Document (CTD)","summary":"1. Introduction","date_modified":"2026-05-08T20:44:59Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/2-the-drug-development-lifecycle-where-regulatory-affairs-adds","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/q4V82Y0\"/><p>Where Regulatory Affairs Add Value</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/2-the-drug-development-lifecycle-where-regulatory-affairs-adds","title":"The Drug Development Lifecycle","summary":"Where Regulatory Affairs Add Value","date_modified":"2026-05-08T20:35:17Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/1-what-is-regulatory-affairs-a-practical-guide-for-life-science","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/D19Qz0w\"/><p>1. Introduction</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/1-what-is-regulatory-affairs-a-practical-guide-for-life-science","title":"What Is Regulatory Affairs? A Practical Guide for Life Science","summary":"1. Introduction","date_modified":"2026-05-08T18:18:41Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/is-innovation-reducing-the-need-for-cmc","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/28715\"/><p>A Global Medicines Development Perspective</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/is-innovation-reducing-the-need-for-cmc","title":"Is Innovation Reducing the Need for CMC? ","summary":"A Global Medicines Development Perspective","date_modified":"2025-11-29T21:30:00Z"},{"id":"https://insightregconsultancy.com/insights-and-resources/f/from-paper-to-platforms","html_content":"<img src=\"https://img1.wsimg.com/isteam/stock/115076\"/><p>How Regulatory Affairs Has Evolved in the Last 20 Years</p>","url":"https://insightregconsultancy.com/insights-and-resources/f/from-paper-to-platforms","title":"From Paper to Platforms ","summary":"How Regulatory Affairs Has Evolved in the Last 20 Years","date_modified":"2025-11-01T16:58:12Z"}]}